InsidersTradesSigma
Follow the 오리엔트바이오 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 오리엔트바이오 has logged 3 insider filings. Market capitalisation: €63.4bn. The latest transaction was filed on 20 March 2026 (Purchase). Among the most active insiders: 오리엔트. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Orient Bio es una empresa que opera en el sector de la salud y farmacéutico, cotizada en la bolsa XKRX. Se enfoca en el desarrollo de productos biológicos y soluciones de diagnóstico.